Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The firm is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.
Mr. James Frakes 2008 'den beri şirketle birlikte olan Aethlon Medical Inc 'in Chief Executive Officer 'ıdır.
AEMD hissesinin fiyat performansı nasıl?
AEMD 'in mevcut fiyatı $2.11 'dir, son işlem günde 0% azalmış etti.
Aethlon Medical Inc için ana iş temaları veya sektörler nelerdir?
Aethlon Medical Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Aethlon Medical Inc 'in piyasa değerlemesi nedir?
Aethlon Medical Inc 'in mevcut piyasa değerlemesi $2.7M 'dir
Aethlon Medical Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 4 analist Aethlon Medical Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 4 tut, 1 sat ve 0 güçlü sat içermektedir